CMI editorial report, 2016 Clinical Microbiology and Infection

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
Cryptococcosis—the impact of delay to diagnosis
Helicobacter pylori resistance to antibiotics in 2014 in France detected by phenotypic and genotypic methods  A. Ducournau, L. Bénéjat, E. Sifré, E. Bessède,
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
I.J. Schalk  Clinical Microbiology and Infection 
O.J. Dyar, G. Tebano, C. Pulcini  Clinical Microbiology and Infection 
D. Khalil, M. Hultin, M.U. Rashid, B. Lund 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Migrant health—a cause for concern?
Images in CMI Clinical Microbiology and Infection
Emerging issues on hepatitis C virus infection after the introduction of the Directly Acting Antivirals  G. Ippolito  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
Screening of migrants for tuberculosis identifies patients with multidrug-resistant tuberculosis but is not sufficient  P. Helbling  Clinical Microbiology.
Refugee crisis and re-emergence of forgotten infections in Europe
R. Cantón  Clinical Microbiology and Infection 
A.E. Muller, U. Theuretzbacher, J.W. Mouton 
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Should standardized susceptibility testing for microbial biofilms be introduced in clinical practice?  T. Coenye, D. Goeres, F. Van Bambeke, T. Bjarnsholt 
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
First isolation of Akkermansia muciniphila in a blood-culture sample
Hepatitis C: global epidemiology and strategies for control
Vector control: a cornerstone in the malaria elimination campaign
Do we need new antibiotics?
CMI editorial report 2013 Clinical Microbiology and Infection
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts  R. Freeman 
Isospora belli Clinical Microbiology and Infection
Epidemiology of opportunistic infections in AIDS patients
Cutaneous myiasis—a stowaway from Central America
CMI editorial report 2011 Clinical Microbiology and Infection
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
Elements of design: the knowledge on which we build
Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines  N. Aliabadi, J.E. Tate, U.D. Parashar  Clinical.
The role of tigecycline in the management of Clostridium difficile infection: a retrospective cohort study  E. Manea, J. Sojo-Dorado, R.E. Jipa, S.N.
Levofloxacin in the treatment of ventilator-associated pneumonia
R. Bitterman, M. Paul, D. Polak, Y. Geffen 
Metagenomics and probiotics
Previously unknown species of Aspergillus
Symposia and Oral Presentations
Impact of obesity on the risk of wound infection following surgery: results from a nationwide prospective multicentre cohort study in England  S. Thelwall,
Sexually acquired Zika virus: a systematic review
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Testing patients with non-specific symptoms for antibodies against Borrelia burgdorferi sensu lato does not provide useful clinical information about.
Vaccinations against respiratory tract infections at Hajj
C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D
Editorial Board Orthopedic Clinics Volume 48, Issue 3, (July 2017)
Editorial Board Orthopedic Clinics Volume 47, Issue 3, (July 2016)
S. M. Bartsch, J. A. McKinnell, L. E. Mueller, L. G. Miller, S. K
Increasing numbers of hospitalizations and deaths with mention of Clostridium difficile infection, north-eastern Italy, 2008–2013  U. Fedeli, E. Schievano,
Clinical Microbiology and Infection
M.T. Pérez-Rodríguez, A. Sousa, P. Martínez-Cueto, A. Ocampo 
A. van Samkar, M. C. Brouwer, Y. Pannekoek, A. van der Ende, D
Volume 49, Issue 1, Pages v-vi (January 2018)
Survival of rhinoviruses on human fingers
The atypical pneumonias: clinical diagnosis and importance
Virology: a scientific discipline facing new challenges
R. Khatib, G. Simeunovic, M. Sharma, M. G. Fakih, L. B. Johnson, L
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Molecular history of plague
Great oaks from little acorns grow—21 years of CMI
Impact of antibiotic restrictions: the patient's perspective
The burden of chikungunya in the Pacific
Editorial Board Orthopedic Clinics Volume 47, Issue 2, (April 2016)
CMI readers' survey Clinical Microbiology and Infection
Volume 50, Issue 2, Pages iii-iv (April 2019)
Rajko Saletinger, Mario Poljak, Franc Strle 
The future of diagnostic bacteriology
Presentation transcript:

CMI editorial report, 2016 Clinical Microbiology and Infection M. Leffad, D. Raoult  Clinical Microbiology and Infection  Volume 22, Issue 1, Pages 1-7 (January 2016) DOI: 10.1016/j.cmi.2015.10.028 Copyright © 2015 Terms and Conditions

Fig. 1 Evolution of CMI's thematic coverage between 2013 and 2015. Clinical Microbiology and Infection 2016 22, 1-7DOI: (10.1016/j.cmi.2015.10.028) Copyright © 2015 Terms and Conditions

Fig. 2 Reason articles are directly discharged. Clinical Microbiology and Infection 2016 22, 1-7DOI: (10.1016/j.cmi.2015.10.028) Copyright © 2015 Terms and Conditions

Fig. 3 CMI's Impact Factor evolution since 2002. Clinical Microbiology and Infection 2016 22, 1-7DOI: (10.1016/j.cmi.2015.10.028) Copyright © 2015 Terms and Conditions